|
Morales ML, Cano H, de la Morena-Barrio B, Vives-Corrons JL, Cuenca-Zamora EJ, Garrido-Rodriguez P, Bento C, Pereira J, Martinez Nieto J, Chen-Liang TH, Fuster JL, Caracena S, Lozano ML, Teruel-Montoya R, Corral J, Ferrer-Marin F. CALRins5-mediated clonal hematopoiesis causes severe hemolytic anemia in a female PGK1Ser320Asn carrier. Blood Cancer J. 2025 Feb 1;15(1):8. doi: 10.1038/s41408-025-01216-w. No abstract available. PubMed PMID: 39893164; PubMed Central PMCID: PMC11787284.
AÑO: 2025; IF: 12.9
|
39893164
|
Santaliestra M, Garrote M, Noya MS, Perez-Encinas M, Senin A, Perez-Lopez R, Ferrer-Marin F, Carreno-Tarragona G, Caballero G, Magro E, Velez P, Cortes Vazquez MA, Moreto A, Angona A, Pastor-Galan I, Guerra JM, Garcia Hernandez C, Mata MI, Stuckey R, Gomez-Casares MT, Fox L, Cuevas B, Garcia-Gutierrez V, Triguero A, Arellano-Rodrigo E, Hernandez-Boluda JC, Alvarez-Larran A. Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia. Leukemia. 2024 Dec;38(12):2636-2643. doi: 10.1038/s41375-024-02416-2. Epub 2024 Sep 27. PubMed PMID: 39333760.
AÑO: 2024; IF: 12.8
|
|
Mosquera-Orgueira A, Arellano-Rodrigo E, Garrote M, Martin I, Perez-Encinas M, Gomez-Casares MT, Hernandez-Sanchez A, Ferrer-Marin F, Mora E, Velez P, Ayala R, Angona A, Heras NL, Magro E, Perez-Miguez C, Crucitti D, Mata-Vazquez MI, Fox ML, Gonzalez de Villambrosia S, Ramirez MJ, Garcia A, Garcia-Gutierrez V, Caceres A, Duran MA, Senin MA, Raya JM, Gonzalez JA, Cuevas B, Xicoy B, Nangalia J, Hernandez-Rivas JM, Bellosillo B, Alvarez-Larran A, Hernandez-Boluda JC; Spanish MPN Group (GEMFIN). Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis. Hemasphere. 2024 Mar 20;8(3):e60. doi: 10.1002/hem3.60. eCollection 2024 Mar. No abstract available. PubMed PMID: 38510992; PubMed Central PMCID: PMC10951878.
AÑO: 2024; IF: 7.6
|
|
Cuenca-Zamora EJ, Guijarro-Carrillo PJ, Lopez-Poveda MJ, Morales ML, Lozano ML, Gonzalez-Conejero R, Martinez C, Teruel-Montoya R, Ferrer-Marin F. miR-146a-/- mice model reveals that NF-kappaB inhibition reverts inflammation-driven myelofibrosis-like phenotype. Am J Hematol. 2024 Jul;99(7):1326-1337. doi: 10.1002/ajh.27322. Epub 2024 Apr 22. PubMed PMID: 38646919.
AÑO: 2024; IF: 10.1
|
|
Segura-Diaz A, Stuckey R, Florido Y, Sobas M, Alvarez-Larran A, Ferrer-Marin F, Perez-Encinas M, Carreno-Tarragona G, Fox ML, Tazon Vega B, Cuevas B, Lopez Rodriguez JF, Sanchez-Farias N, Gonzalez-Martin JM, Gomez-Casares MT, Bilbao-Sieyro C; Spanish MPN Group (GEMFIN). DNMT3A/TET2/ASXL1 Mutations are an Age-independent Thrombotic Risk Factor in Polycythemia Vera Patients: An Observational Study. Thromb Haemost. 2024 Jul;124(7):669-675. doi: 10.1055/a-2239-9265. Epub 2024 Jan 8. PubMed PMID: 38190984; PubMed Central PMCID: PMC11199052.
AÑO: 2024; IF: 5.0
|